Hypoguard has received 510(k) clearance from the US FDA to market its Assure Pro Blood Glucose Monitoring System.

Assure Pro is specifically designed for multi-resident use in long-term care (LTC) facilities. This full-featured system offers qcProGuard, the first of its kind, 24-hour reminder to conduct daily control solution testing as required in LTC settings. A "Hypo" warning alerts users of low blood glucose readings and four programmable alarms can be used as test reminders.

According to the company release, Assure Pro Test Strips are built using platinum technology and requires a small blood sample size (1 µL). To test, simply insert the test strip in the convenient top-of-the-meter port. Results are displayed in 10 seconds on a large LCD and a backlight display (adjustable) assists for reading in low light conditions. A strip release button for strip disposal eliminates the need to touch a used strip, reducing the risk of exposure to infectious materials. For additional security, Assure Pro is designed with ProGrip to help secure a hold on the meter and reduce slipping on surfaces.

Dave Conn, President of Hypoguard USA said, "Many of the features in this system were designed based on feedback from healthcare professionals. This innovative, easy-to-use, and full-featured blood glucose system meets the diverse needs of healthcare workers. We expect this to become the premier product in LTC."